| Systematic (IUPAC) name | |
|---|---|
| 3-(piperazin-1-yl)-9H-dibenzo[c,f][1,2,4]triazolo[4,3-a]azepine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Uncontrolled |
| Routes | ? |
| Identifiers | |
| CAS number | 90685-01-1 |
| ATC code | None |
| PubChem | CID 146222 |
| ChemSpider | 128982 |
| Chemical data | |
| Formula | C19H19N5 |
| Mol. mass | 317.39 g/mol |
| SMILES | eMolecules & PubChem |
Pitrazepin is a competitive GABAA and glycine receptor antagonist.[1][2][3] It has been used to study insect and snail nervous systems in scientific research.[4][5][6][7][8][9]
|
||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)